期刊文献+

骨髓增殖性疾病JAK2V617F与46/1 JAK2基因单体型的关系及46/1单体型在中国不同民族中的分布 被引量:3

Relationship between V617F Mutation and 46/1 Haplotype in JAK2 Gene in Patients with Chronic Myeloproliferative Diseases and Frequencies of 46/1 Haplotype in Different Chinese Nationalities
下载PDF
导出
摘要 体细胞基因JAK2V617F突变是诊断骨髓增殖性疾病(MPD)最主要的分子生物学标志。本研究旨在探索中国MPD患者中JAK2V617F是否与46/1 JAK2基因单体型(rs12343867,简称46/1)基因易感性相关,确定46/1在MPD患者及健康汉族、藏族、裕固族人群中的分布。采集了150例JAK2V617F突变阳性的MPD患者、123例JAK2V617F突变阴性的MPD患者、124例健康汉族人、395例健康藏族人及315例健康裕固族人的外周血或者骨髓样本,建立了一种能够同时分析JAK2V617F和46/1是否位于同一等位基因上的ARMS-PCR方法,比较有和无JAK2V617F基因突变的MPD患者46/1 JAK2基因单体型检出率的差异,分析中国健康汉族、藏族、裕固族人群中46/1 JAK2基因单体型的分布特征。结果显示:在150例能检出JAK2V617F突变的MPD患者中,有88例(58.67%)的JAK2V617F突变发生在46/1基因单体型上。在814例健康中国人中,46/1基因单体型的检出率为38.37%,3个民族中的检出率无差别,健康人中未检测出JAK2V617F突变。在JAK2V617F突变阴性的MPD患者中46/1单体型的检出率为43.09%,而在JAK2V617F突变阳性的MPD患者中46/1基因单体型的检出率为69.33%,远高于JAK2V617F突变阴性的MPD患者和健康人。结论:建立了一种能够同时分析JAK2V617F和46/1是否位于同一等位基因上的ARMS-PCR方法;中国MPD患者JAK2V617F基因突变大部分发生在46/1等位基因上;46/1单体型在中国健康汉族人、藏族人及裕固族人中分布没有明显差异。 Somatic gene V617F mutation in JAK2 is a critical molecular and biological indicator to diagnosis of chronic myeloproliferative disease(MPD).This study was aimed to investigate the genetic background of V617F mutation in 46/1 gene haplotype in Chinese MPD patients,and the frequencies of 46/1 gene haplotype and V617F mutation in three nationalities of Chinese populations.Peripheral blood or bone marrow samples of 150 V617F mutation positive MPD patients,123 V617F mutation negative MPD patients,124 healthy Han individuals,395 healthy Tibetan individuals and 315 healthy Yugu individuals were collected.The allele-specific multiplex PCR method was established,the presence or absence of V617F mutation,the presence or absence of 46/1 haplotype,and the relationship between V617F and 46/1 haplotype were easily identified by agarose gel image.The results showed that the V617F mutation located in the 46/1 haplotype of 88 cases(58.67%) among 150 V617F-positive MPD cases.In 814 Chinese healthy individuals including Han,Tibetan,Yugu nationalities,the frequency of the 46/1 gene haplotype was 38.37% without difference in the frequency among different nationalities,and no V617F mutation was found in Chinese healthy populations,The frquency of the 46/1 gene haplotype was 43.09% in V617F mutation negative MPD patients and was 69.33% in V617F mutation positive MPD patients,the latter was obviously higher than former and than that in healthy Han individuals.In conclusion,a multiplex PCR method has been developed that is simple and useful to identify V617F mutation in JAK2 gene and its relationship to the 46/1 haplotype.In more than half of Chinese V617F-positive MPD patients,the V617F mutation locates in 46/1 haplotype in JAK2.The frequencies of 46/1 haplotype are statistically insignificant among Han,Tibetan and Yugu nationality populations.
出处 《中国实验血液学杂志》 CAS CSCD 北大核心 2012年第2期362-367,共6页 Journal of Experimental Hematology
关键词 骨髓增殖性疾病 JAK2V617F 46/1JAK2单体型 中国汉族 中国藏族 中国裕固族 SNP myeloproliferative disorder JAK2V617F 46/1 haplotype Chinese Han Chinese Tibetan Chinese Yugu
  • 相关文献

参考文献3

二级参考文献50

  • 1赵峻峰,朱平,张英,杜金伟,刘红星,刘静,庄昕,邱志祥.实时定量聚合酶链反应在急性早幼粒细胞白血病融合基因检测中的临床应用[J].中华检验医学杂志,2006,29(5):424-427. 被引量:5
  • 2朱平.骨髓增殖性疾病JAK2基因突变的临床意义[J].中华医学杂志,2006,86(32):2243-2245. 被引量:14
  • 3James C,Ugo V,Le-Couédic JP,et al.A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera.Nature,2005 ,434:1144-1148
  • 4Tefferi A,Vardiman JW.Classification and diagnosis of myeloproliferative neoplasms, the 2008 World Health Organization criteria and point-of-care diagnostic algorithms.Leukemia,2008,22:14 -22
  • 5Lippert E,Boissinot M,Kralovics R,et al.The JAK2V617F mutation is frequently present at diagnosis in patients with essential thrombocythemia and polycythemia vera.Blood,2006, 108:1865-1867
  • 6Scott LM,Scott MA,Campbell PJ,et al.Progenitors homozygous for the V617F mutation occur in most patients with polycythemia vera,but not essential thrombocythemia.Blood,2006, 108:2435 -2437
  • 7Antonioli E,Guglielmelli P,Pancrazzi A,et al.Clinical implications of the JAK2 V617F mutation in essential thrombocythemia.Leukemia,2005 ,19:1847-1849
  • 8Vardiman JM,Harris NC,Brunning RD.The World Health Organization (WHO) classification of the myeloid neoplasms.Blood,2002, 100:2292-2302
  • 9Dupont S,Masse A,James C,et al.The JAK2617V > F mutation triggers erythropoietin hypersensitivity and terminal erythroid amplification in primary cells from patients with polycythemia vera.Blood,2007, 110:1013-1021
  • 10Finazzi C,Rambaldi A,Cuerini V,et al.Risk of thrombosis in patients with essential thrombocythemia and polycythemia vera according to JAK2V617F mutation status.Haematologica,2007 ,92:135 -136

共引文献20

同被引文献25

  • 1韦叶生,赵邦,唐任光,蒙兰青.广西壮族人群ICAM-1基因多态性及血清水平与脑梗死关系的研究[J].现代免疫学,2005,25(1):66-69. 被引量:8
  • 2汪明,李艳,张平安,杨相升,周心房,李晓艳,黄从新.冠心病患者细胞间黏附分子1基因多态性与其他暴露因素的交互作用的研究[J].中华检验医学杂志,2006,29(12):1123-1128. 被引量:5
  • 3Blume-Jensen p, Hunter T. Oncogenic Kinase Signaling[J]. Nature, 2001, 411: 355-365.
  • 4Aljedai A, Buckle AM, Hiwarkar P, et al. Potential Role of Notch Signalling in CD34 + Chronic Myeloid Leukaemia Cells: Cross-Talk between Notch and BCR-ABL[J]. PLoS One, 2015, 10(4): e0123016.
  • 5Lin v, Liu E, Sun Q, et al. The Prevalence ofJAK2, MPL, and CALRMutations in Chinese Patients with BCR?ABU-Negative Myeloproliferative Neoplasms[J]. AmJ Clin Pathol , 2015, 144(1): 165-171.
  • 6YangJ J, Chen H, Zheng X Q, et al. Methylated Alteration of SHP1 Complements Mutation ofJ AK2 Tyrosine Kinase in Patients with Myeloproliferative Neoplasm[J]. Asian PacJ Cancer Prev , 2015, 16( 6): 2219-2225.
  • 7Pomicter A D, Eiring A M, Senina A V, et al. Limited Efficacy of BM3-911543 in a Murine Model ofJanus Kinase 2 V617F Myeloproliferative Neoplasm[J]. Exp Hematol. 2015. 43(7): 537-545.
  • 8James C. U go V. Le CouedicJ P. et al. A Unique ClonalJ AK2 Mutation Leading to Constitutive Signalling Causes Polycythaemia Vera[J]. Nature. 2005, 434: 1144-1148.
  • 9Jones A V, Campbell PJ, Beer P A, et al. TheJ AK2 46/1 Haplotype Predisposes to MPL-Mutated Myeloproliferative Neoplasms[J]. Blood. 2010. 115 (22): 4517-4523.
  • 10Zhao R. Xing S. Li Z, et al, Identification of an AcquiredJAK2 Mutation in Polycythemia Vera[J].J Bioi Chern. 2005, 280(24): 22788-22792.

引证文献3

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部